No Data
Vaxart Project Agreement Change Ups Funding for Oral COVID Vaccine Candidate
Sector Update: Health Care Stocks Lower in Late Afternoon Trading
Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study
Express News | Vaxart - Funding Ceiling Increased to About $460.7 Million; Funding for Trial Increased to About $134.2 Million
Express News | Vaxart Inc - Enters Into Modification No. 4 to Project Agreement With Advanced Technology International
The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA
Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.